Journal of Neurology

, Volume 240, Issue 7, pp 417–422 | Cite as

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

  • Oluf Andersen
  • Per-Erik Lygner
  • Tomas Bergström
  • Mats Andersson
  • Anders Vablne
Original Communications


A neurological surveillance was combined with prospective recording of upper respiratory and gastrointestinal infections and serological diagnosis of five common viral infections in 60 benign multiple sclerosis patients, with a mean follow-up of 31 months. During 4-week at risk (AR) periods encompassing common infections, a significant excess of MS relapses was found in the AR period, with a relative risk of 1.3. A seasonal variation of the MS relapse rate was found with a minimum in summer. There was a significant correlation between the number of AR relapses and the number of common infections per month explaining the periannual distribution of relapses. The non-AR relapses showed no seasonal variation. There was a significant correlation between adenovirus CF titre rises associated with upper respiratory infections and the occurrence of a major MS relapse in the AR period (n = 7), while influenza infections were not followed by a major MS relapse (n = 6). Linear homologies have been demonstrated between adenovirus and basic myelin protein. The epidemiological approach is essential to our understanding of systemic antigens triggering multiple sclerosis activity.

Key words

Multiple sclerosis Viral infection Epidemiology Adenovirus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alvord EC Jr, Jahnke U, Fischer EH, et al (1987) The multiple causes of multiple sclerosis: the importance of age of infections in childhood. J Child Neurol 2:313–321PubMedCrossRefGoogle Scholar
  2. 2.
    Andersen O (1980) Restricted dissemination of clinically defined attacks in an MS incidence material. Acta Neurol Scand 62 [Suppl 77] 18Google Scholar
  3. 3.
    Bernard C, Townsend E, Randell VB, Williamson HG (1983) Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol 52:98–106PubMedPubMedCentralGoogle Scholar
  4. 4.
    Dean G, Kurtzke JF (1971) On the risk of multiple sclerosis according to age at immigration to South Africa. BMJ 3:725–729PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Ebers GC, Bulman DE, Sadovnick AD, et al (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315:1638–1642PubMedCrossRefGoogle Scholar
  6. 6.
    Edwards JH (1961) The recognition and estimation of cyclic trends. Ann Hum Genet 25:83–87PubMedCrossRefGoogle Scholar
  7. 7.
    Fujinami RS, Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230:1043–1045PubMedCrossRefGoogle Scholar
  8. 8.
    Gay D, Dick G, Upton G (1986) Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet 1:815–819PubMedCrossRefGoogle Scholar
  9. 9.
    Gwaltney JM Jr (1985) Virology and immunology of the common cold. Rhinology 23:265–271PubMedGoogle Scholar
  10. 10.
    Hammond SR, McLeod JG, Millingen KS, et al (1988) The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 111:1–25PubMedCrossRefGoogle Scholar
  11. 11.
    Jahnke U, Fischer EH, Alvord EC Jr (1985) Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 229:282–284PubMedCrossRefGoogle Scholar
  12. 12.
    Kurtzke JF (1970) Clinical manifestations of multiple sclerosis. In: Vinken PJ, Bruyn GW (ed) Handbook of clinical neurology, vol 9. North-Holland, Amsterdam, p 161Google Scholar
  13. 13.
    Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disabiliy status scale (EDSS) Neurology 33:1444–1452PubMedCrossRefGoogle Scholar
  14. 14.
    Mårtensson E, Axelsson R, Oden A (1980) Prophylactic effect of continuous treatment with antidepressants. Curr Ther Res 28:767–776Google Scholar
  15. 15.
    Merck C, Angervall L, Kindblom LG, Odén A (1983) Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathological and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand [Suppl] 282:1–40Google Scholar
  16. 16.
    Norrby E, Veen J van der, Espmark A (1970) A new serological technique for identification of adenovirus infections. Proc Soc Exp Biol Med 134:889–895PubMedCrossRefGoogle Scholar
  17. 17.
    Panitch HS, Bever T, Katz E, Johnson KP (1991) Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon. J Neuroimmunol [Suppl 1]:125Google Scholar
  18. 18.
    Poser CM, Paty DW, Scheinberg L, et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231PubMedCrossRefGoogle Scholar
  19. 19.
    Salmi A, Reunanen M, Ilonen J, Panelius M (1983) Intrathecal antibody synthesis to virus antigens in multiple sclerosis. Clin Exp Immunol 52:241–249PubMedPubMedCentralGoogle Scholar
  20. 20.
    Schapira K (1959) The seasonal incidence of onset and exacerbations in multiple sclerosis. J Neurol Neurosurg Psychiatry 22:285–286PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Schauf CL, Davis FA (1974) Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents. J Neurol Neurosurg Psychiatry 37:152–161PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Shaw SY, Laursen RA, Lees MB (1986) Analogous amino acid sequences in myelin proteolipid and viral proteins. FEBS Lett 207:266–270PubMedCrossRefGoogle Scholar
  23. 23.
    Sibley WA, Foley JM (1965) Infection and immunization in multiple sclerosis. Ann NY Acad Sci 122:457–466PubMedCrossRefGoogle Scholar
  24. 24.
    Sibley WA, Foley J (1965) Seasonal variation in multiple sclerosis and retrobulbar neuritis in Northeastern Ohio. Trans Am Neurol Assoc 90:295–297Google Scholar
  25. 25.
    Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet I:1313–1315CrossRefGoogle Scholar
  26. 26.
    Svenningsson A, Runmarker B, Lycke J, Andersen O (1990) Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 82:161–168PubMedCrossRefGoogle Scholar
  27. 27.
    Vartdal F (1989) HLA associations in multiple sclerosis: implications for immunopathogenesis. Res Immunol 140:192–196PubMedCrossRefGoogle Scholar
  28. 28.
    Weise MJ, Carnegie PR (1988) An approach to searching protein sequences for superfamily relationships or chance similarities relevant to the molecular mimicry hypothesis: application to the basic proteins of myelin. J Neurochem 51:1267–1273PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Oluf Andersen
    • 1
  • Per-Erik Lygner
    • 1
  • Tomas Bergström
    • 2
  • Mats Andersson
    • 1
  • Anders Vablne
    • 2
  1. 1.Department of NeurologyUniversity of GothenburgGothenburgSweden
  2. 2.Department of VirologyUniversity of GothenburgGothenburgSweden

Personalised recommendations